Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Candyswanwickon Jul 22, 2017 2:40pm

210 Views

Post# 26498204

RE:No material change...

love_minus_zero wrote: In the absence of material change this security has become, by default, one of the most manipulated stocks on the TSX.
Fact.
lmz

agree about the manipulation, but use the ups and downs to trade... you said earlier that you trade.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!